Connect
MJA
MJA

Progress in stem cell research and the role of law

Ian H Kerridge and Aric Bendorf
Med J Aust 2011; 194 (4): 156-157.
Published online: 21 February 2011

Is it time to relax or tighten the legislation on human embryo research?

Over the past decade, human embryo research has generated both enormous scientific interest and extensive public debate. In response to this, Australia passed two Acts in 2002: the Research Involving Human Embryos Act 2002 (Cwlth) and the Prohibition of Human Cloning Act 2002 (Cwlth). Together, these Acts, and mirror legislation passed by all states and territories, enabled Australian scientists to undertake specific research involving human embryos, provided that they obtained a licence from the Embryo Research Licensing Committee of the National Health and Medical Research Council (NHMRC), reported regularly to this committee, and had their research approved and monitored by the appropriate institutional ethics committee. At the same time, these Acts prohibited a series of practices — including human cloning, creation of animal–human cybrids, maturation of research embryos beyond 14 days, and the buying and selling of human oocytes — and provided substantial penalties for breaches of the provisions.

  • Ian H Kerridge1,2
  • Aric Bendorf1

  • 1 Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, NSW.
  • 2 Westmead Hospital, Sydney, NSW.


Competing interests:

Ian Kerridge is a Board Member of the NSW Stem Cell Network and was a member of the Lockhart Committee in 2006.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.